By Bobby Sheng
‘Business Preparedness’ is a term rarely used outside the boardroom, but in light of the COVID-19 crisis, it’s gaining new relevance. Currently, it’s on everyone’s agenda and at the forefront of most internal meetings.
Pharma has had to react and respond very quickly, in order to manage the pandemic’s potential impact, which has led many to immediately set into motion a series of initiatives to ensure that we responded effectively.
Global problem, global response
Pharma and government agencies are responding around the world, working vigorously on a number of fronts to combat the virus. Taiwan, for example, has been recognized in the media for its efforts to help stop the disease on both social and scientific fronts.
As a global pharmaceutical developer and contract manufacturing supply chain partner in Taiwan, we’ve yet to experience any significant impact from the pandemic and we may owe much of it to our country’s vigorous response. From a business preparedness standpoint globally, we acted swiftly and secured all our facilities in a similar manner.